Dr Massimo Cristofanilli, MD Joins Datar Cancer Genetics as Strategic Advisor

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

DATAR-CANCER

More Like This

PR Newswire associated0

Datar Cancer Genetics to Provide Groundbreaking Video-Enhanced Results of In-Vitro Chemotherapy Effectiveness Tests for Cancer Patients

PR Newswire associated0

Datar Cancer Genetics Unveils Next Generation Multi-Analyte, AI-Powered Decision Support Platform for Personalized Treatment of Difficult-to-Treat Cancers.

PR Newswire associated0

Datar Cancer Genetics Introduces Revolutionary Tumor-Agnostic + Informed Blood Test for Residual Disease Monitoring

PR Newswire associated0

MGI: Closing the Cancer Care Gap with the Power of Precision Oncology

Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications

PR Newswire associated0

Cancer: Crosetto's Breakthrough Inventions with Potential to Save Millions of Lives and Billions of Dollars Approved for a Two-Hour Presentation at IEEE

First results from PEGASUS trial reported at ESMO show promise for use of liquid biopsy to guide adjuvant treatment of colon cancer

PR Newswire associated0

Menarini Silicon Biosystems announces new study results on use of CELLSEARCH® liquid biopsy for earlier detection of relapse and to help inform decisions on patient management in stage III Melanoma